ORPHA:1652
Dent disease
Also known as: Dent syndrome · Low-molecular-weight proteinuria with hypercalciuria and nephrocalcinosis · Renal Fanconi syndrome with nephrocalcinosis and renal stones · X-linked recessive hypercalciuric hypophosphatemic rickets · X-linked recessive nephrolithiasis
Publications
873
84.4th percentile
Trials
2
Interventional, condition-specific
Researchers
1,116
Distinct authors in sample
Gene link
—
Readiness
4/6
Stages with a signal
Clinical definition (Orphanet)
A rare X-linked renal tubular diseases characterized by a primary proximal tubule dysfunction with low-molecular-weight proteinuria. Other renal features often include hypercalciuria, nephrolithiasis/nephrocalcinosis, and renal failure, among others. There are two subtypes: Dent disease type 1 characterized by an isolated renal in association with CLCN5 variants, and Dent disease type 2, often characterized by the addition of extra renal manifestations in association with OCRL1 variants.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0015612
- MeSH:D057973
- UMLS:C0878681
- NCIT:C123260
Additional Mondo synonyms (3)
X-linked recessive hypophosphatemic rickets · low-molecular-weight proteinuria with hypercalciuria and nephrocalcinosis · renal Fanconi syndrome with nephrocalcinosis and renal stones
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
873 matched papers (575 in last 10 years) Source
- Phenotype characterisedPresent
86 HPO annotations (e.g. Renal insufficiency; Renal tubular atrophy; Proteinuria) Source
- Animal modelPresent
4 genotype models (Mus musculus) Source
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
2 matched on ClinicalTrials.gov
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
86
Associated phenotypes · MONDO:0015612
- Renal insufficiency
- Renal tubular atrophy
- Proteinuria
- Enlargement of the wrists
- Renal hypophosphatemia
Showing 5 of 86 — open Monarch for the full list.
Animal models (Monarch / Alliance)
4
Model associations linked to this Mondo ID
- Clcn5tm1Gug/Y [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6J·MGI:3510236·Mus musculus
- Clcn5tm1Tjj/Y [background:] B6.129-Clcn5tm1Tjj·MGI:3046533·Mus musculus
- Inpp5btm1Nbm/Inpp5btm1Nbm Ocrltm1Nbm/Ocrltm1Nbm Tg(INPP5B)CNbm/0 [background:] involves: 129S/SvEv * 129S6/SvEvTac * FVB/N·MGI:5430751·Mus musculus
- Inpp5btm1Nbm/Inpp5btm1Nbm Ocrltm1Nbm/Y Tg(INPP5B)CNbm/0 [background:] involves: 129S/SvEv * 129S6/SvEvTac * FVB/N·MGI:5430752·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
2
Drugs / clinical candidates · MONDO_0015612
- AMILORIDE·phase 2 3
- HYDROCHLOROTHIAZIDE·phase 2 3
CTD chemicals (MyDisease.info)
1 associated chemical · 3 pathways. Therapeutic evidence is listed first when present — not a treatment recommendation.
- Hydrochlorothiazide · therapeutic
Pathways: Stimuli-sensing channels; Transmembrane transport of small molecules; Ion channel transport
Literature
Is anyone studying this?
873
873 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
873 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
575 in the last 10 years · medium confidence · 84.4th percentile (publications denominator)
Phrase hits: 873 · MeSH hits: 0
Who's working on it?
1,116
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Anglani F11 papers · 2026
Kidney Histomorphology and Molecular Biology Laboratory, Nephrology, Dialysis and Transplantation Unit, Department of Medicine-DIMED, University of Padua, 35128 Padua, Italy.
Papers in Europe PMC - 02Nozu K10 papers · 2026
Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Papers in Europe PMC - 03Sakakibara N8 papers · 2026
Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Papers in Europe PMC - 04Del Prete D7 papers · 2026
Kidney Histomorphology and Molecular Biology Laboratory, Nephrology, Dialysis and Transplantation Unit, Department of Medicine-DIMED, University of Padua, 35128 Padua, Italy.
Papers in Europe PMC - 05Horinouchi T7 papers · 2026
Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Papers in Europe PMC - 06Lieske JC7 papers · 2026
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.
Papers in Europe PMC - 07Nagano C7 papers · 2026
Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan. china@med.kobe-u.ac.jp.
Papers in Europe PMC - 08Yamamura T7 papers · 2026
Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Papers in Europe PMC - 09Ceol M6 papers · 2026
Kidney Histomorphology and Molecular Biology Laboratory, Nephrology, Dialysis and Transplantation Unit, Department of Medicine-DIMED, University of Padua, 35128 Padua, Italy.
Papers in Europe PMC - 10Ishimori S6 papers · 2026
Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
2
interventional trials for this specific condition
2 interventional trials matched this specific condition name; none in our sample are currently recruiting.
Data as of 11 September 2026
2 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 84.5th percentile).
medium confidence · 84.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
2 interventional trials matched after quoted-phrase search and title/condition post-filter.
No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.
Observational and natural-history studies
8 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT00588562·RECRUITING·Rare Kidney Stone Consortium Patient Registry
Not reviewed·Conditions: Primary Hyperoxaluria · Dent Disease · Cystinuria · APRT Deficiency·Matched via name phrase
- NCT02026388·RECRUITING·Rare Kidney Stone Consortium Biobank
Not reviewed·Conditions: Primary Hyperoxaluria · Dent Disease · APRT Deficiency · Cystinuria·Matched via name phrase
- NCT06065852·RECRUITING·National Registry of Rare Kidney Diseases
Not reviewed·Conditions: Adenine Phosphoribosyltransferase Deficiency · AH Amyloidosis · AHL Amyloidosis · AL Amyloidosis·Matched via name phrase
- NCT06017193·RECRUITING·Ultrasound for Socket Healing Evaluation
Not reviewed·Conditions: Healing Wound · Alveolar; Wound · Alveolar Bone Loss · Image·Matched via name phrase
- NCT02780297·RECRUITING·Prospective Research Rare Kidney Stones (ProRKS)
Not reviewed·Conditions: Hyperoxaluria · Cystinuria · Dent Disease · Lowe Syndrome·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 11 · after dedupe 11 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 11 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (11)
- isrctn·ISRCTN15852459·No longer recruiting·Diode laser-assisted tooth extraction versus conventional extraction in patients receiving antiplatelet therapy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN53999031·No longer recruiting·Gum stain removal using a ceramic drill
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10631004·No longer recruiting·Evaluation of the residual bone level around explanted implants: local and systemic risk factors
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12989450·No longer recruiting·Parents/caregivers and their children’s experience of dental general anaesthesia
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN26692900·No longer recruiting·The benefits of Nd:YAG laser in the treatment of gum disease in an adult population
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12192375·Recruiting·Longitudinal physiological changes in inherited metabolic disorders
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10993769·No longer recruiting·Should bone grafts in the upper jaw be allowed to heal for 3 or 6 months before inserting dental implants?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN38904316·Stopped·Acceptability and tolerability of a new phe-free protein substitute for the dietary management of patients with phenylketonuria, aged ≥16 years
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN53453484·No longer recruiting·Effects of exercise on Pompe disease
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN00353297·No longer recruiting·Effect of ketofol on persistent pain in patients with cancer that has spread to the bone
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN87342238·No longer recruiting·Conventional implants vs mini implants used to retain full lower dentures
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Dent disease — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Dent disease" OR "Dent syndrome" OR "Low-molecular-weight proteinuria with hypercalciuria and nephrocalcinosis" OR "Renal Fanconi syndrome with nephrocalcinosis and renal stones" OR "X-linked recessive hypercalciuric hypophosphatemic rickets" OR "X-linked recessive nephrolithiasis" OR "X-linked recessive hypophosphatemic rickets"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Dent disease" OR "Dent syndrome" OR "Low-molecular-weight proteinuria with hypercalciuria and nephrocalcinosis" OR "Renal Fanconi syndrome with nephrocalcinosis and renal stones" OR "X-linked recessive hypercalciuric hypophosphatemic rickets" OR "X-linked recessive nephrolithiasis" OR "X-linked recessive hypophosphatemic rickets"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 2 interventional · 8 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is short or not clearly distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T17:51:56.445Z
